Identification et prise en charge d’un haut risque de cancer du sein. État des lieux 2014

C. Tlemsani; S. Delaloge

doi:10.1007/s10269-014-2447-2

Identification et prise en charge d’un haut risque de cancer du sein. État des lieux 2014

Translated title of the contribution: Identification and management of high risks of breast cancer. State of the art in 2014

C. Tlemsani, S. Delaloge

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Breast cancer is the most common cancer diagnosed and the first leading cause of cancer death among women in France. A population of women at high risk of breast cancer (more than 3% risk at 5 years and 20–25% lifetime) can nowadays be identified and benefit from an appropriate personalized prevention and monitoring program. The French national health authority (HAS, Haute Autorité de Santé) considers personal germline mutation of BRCA1/2, TP53, PTEN, CDH1 or STK11/LKB1 genes, but also recently personal breast cancer history, personal history of atypical breast lesion, history of high-dose chest irradiation and striking family breast/ovarian cancer history but without identified mutation, as criteria of high breast cancer risk and provides screening recommendations for these women.

Translated title of the contribution	Identification and management of high risks of breast cancer. State of the art in 2014
Original language	French
Pages (from-to)	413-418
Number of pages	6
Journal	Oncologie
Volume	16
Issue number	9-10
DOIs	https://doi.org/10.1007/s10269-014-2447-2
Publication status	Published - 31 Oct 2014

Access to Document

10.1007/s10269-014-2447-2

Cite this

@article{c75986fcef5e44ae9545eb03d11756a8,

title = "Identification et prise en charge d{\textquoteright}un haut risque de cancer du sein. {\'E}tat des lieux 2014",

abstract = "Breast cancer is the most common cancer diagnosed and the first leading cause of cancer death among women in France. A population of women at high risk of breast cancer (more than 3% risk at 5 years and 20–25% lifetime) can nowadays be identified and benefit from an appropriate personalized prevention and monitoring program. The French national health authority (HAS, Haute Autorit{\'e} de Sant{\'e}) considers personal germline mutation of BRCA1/2, TP53, PTEN, CDH1 or STK11/LKB1 genes, but also recently personal breast cancer history, personal history of atypical breast lesion, history of high-dose chest irradiation and striking family breast/ovarian cancer history but without identified mutation, as criteria of high breast cancer risk and provides screening recommendations for these women.",

keywords = "Breast cancer, High risk breast cancer, Risk factor, Screening",

author = "C. Tlemsani and S. Delaloge",

note = "Publisher Copyright: {\textcopyright} 2014, Springer-Verlag France.",

year = "2014",

month = oct,

day = "31",

doi = "10.1007/s10269-014-2447-2",

language = "Fran{\c c}ais",

volume = "16",

pages = "413--418",

journal = "Oncologie",

issn = "1292-3818",

number = "9-10",

}

TY - JOUR

T1 - Identification et prise en charge d’un haut risque de cancer du sein. État des lieux 2014

AU - Tlemsani, C.

AU - Delaloge, S.

PY - 2014/10/31

Y1 - 2014/10/31

N2 - Breast cancer is the most common cancer diagnosed and the first leading cause of cancer death among women in France. A population of women at high risk of breast cancer (more than 3% risk at 5 years and 20–25% lifetime) can nowadays be identified and benefit from an appropriate personalized prevention and monitoring program. The French national health authority (HAS, Haute Autorité de Santé) considers personal germline mutation of BRCA1/2, TP53, PTEN, CDH1 or STK11/LKB1 genes, but also recently personal breast cancer history, personal history of atypical breast lesion, history of high-dose chest irradiation and striking family breast/ovarian cancer history but without identified mutation, as criteria of high breast cancer risk and provides screening recommendations for these women.

AB - Breast cancer is the most common cancer diagnosed and the first leading cause of cancer death among women in France. A population of women at high risk of breast cancer (more than 3% risk at 5 years and 20–25% lifetime) can nowadays be identified and benefit from an appropriate personalized prevention and monitoring program. The French national health authority (HAS, Haute Autorité de Santé) considers personal germline mutation of BRCA1/2, TP53, PTEN, CDH1 or STK11/LKB1 genes, but also recently personal breast cancer history, personal history of atypical breast lesion, history of high-dose chest irradiation and striking family breast/ovarian cancer history but without identified mutation, as criteria of high breast cancer risk and provides screening recommendations for these women.

KW - Breast cancer

KW - High risk breast cancer

KW - Risk factor

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=84911480932&partnerID=8YFLogxK

U2 - 10.1007/s10269-014-2447-2

DO - 10.1007/s10269-014-2447-2

M3 - Article

AN - SCOPUS:84911480932

SN - 1292-3818

VL - 16

SP - 413

EP - 418

JO - Oncologie

JF - Oncologie

IS - 9-10

ER -

Identification et prise en charge d’un haut risque de cancer du sein. État des lieux 2014

Abstract

Access to Document

Other files and links

Cite this